Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus agomelatine for insomnia symptoms in patients with depression
ChiCTR1800020182Phase 4Recruiting
- Sponsor
- Jiaxing Kangci Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of agomelatine and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Jiaxing Kangci Hospital. Primary endpoints: Polysomnography, Serum melatonin and 2 more. Started Dec 2018; status: recruiting.
02
Drugs
agomelatinesertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR1800020182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020182.